Cisbio Pro-collagen Type 1 (human) and Alpha-SMA kits assay kits, brand name or equal

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
(ii) The solicitation number is 75N95019Q00029 and the solicitation is issued as a request for quotation (RFQ).
This acquisition is for a commercial item and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures; FAR Subpart 13.5- Simplified Procedures for Certain Commercial Items; and FAR Part 12-Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold.
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-101, dated October 26, 2018.
(iv) The associated NAICS code is 325414 and the small business size standard is 1,250 employees. This requirement is full and open with no set-aside restrictions.
DESCRIPTION
(v) NCATS seeks to purchase twelve (12) Cisbio, or brand-name equal, assay kits: six (6) Pro-collagen Type 1 (human) kits and six (6) Alpha-SMA kits. The specific brand-name product codes and salient characteristics are as follows:
Name: Pro-collagen Type 1 (human) kits
Quantity: Six (6)
Manufacturer: Cisbio
Product Code: 63ADK014PEH
Salient Characteristics
• Sandwich immunoassay detecting human pro-collagen type 1
• Detectable in a sandwich assay format using two (2) different specific monoclonal antibodies, one labeled with Europium Cryptate (donor) and the second with d2 (acceptor)
• Allows detection of human pro-collagen type 1 in cell supernatants
• Allows quantification of human pro-collagen type 1 in cell supernatants
• Allows functional screening of compounds using Human pro-collagen type 1 secreting cells
• Allows for low volume sample size needed
• Good for live cell, supernatant, and biochemical-based protocols
• Comes as all-in-one ready to use kit with no necessity of additional purchase of components to make it work
Ideally it will come with a simple "add & read" protocol, no washing step.
Name: Alpha-SMA assay kits
Quantity: Six (6)
Manufacturer: Cisbio
Product Code: 62ASMAPEH
Salient Characteristics
• Cell-based and able to measure expression level of alpha-SMA tissue fibrosis
• Specific for alpha-SMA isoforms
• Compatible with both human and mouse species
• Able to identify anti-fibrotic compounds
• Has high sensitivity, preferably at the endogenous level of alpha-SMA in LX-2 cell lines
• Optimized for 96- and 384-well plates protocol
• Good to run in both frozen cell lysates and/or fresh cell lines
(vi) Delivery of the kits is to occur within thirty (30) days after receipt of order and shall be made to the below address with FOB Destination. A specific point of contact will be indicated on the purchase order.
National Center for Advancing Translational Sciences
9800 Medical Center Drive
Rockville, MD 20850
(vii) The Government plans to award a contract resulting from this solicitation. The resulting award will be made to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate quotations: Technical Capability, Past Performance, and Price.
(viii) The anticipated award date is Friday, January 11, 2019.
PROVISIONS AND CLAUSES
(ix) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998). This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at this/these address(es): www.acquisition.gov.
The following provisions apply to this acquisition and are incorporated by reference:
• The provision at FAR 52.204-7, System for Award Managemen t (Oct 2018)
• The provision at FAR 52.204-16, Commercial and Government Entity Code Reporting (Jul 2016)
• The provision at FAR 52.211-6, Brand Name or Equal (Aug 1999)
• The provision at FAR 52.212-1, Instructions to Offerors - Commercial Items (Oct 2018)
• The provision at 52.212-3, Offeror Representations and Certifications-Commercial Items (Oct 2018)
(x) The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998). This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this/these address(es): www.acquisition.gov.
The following clauses apply to this acquisition and are incorporated by reference:
• The clause at FAR 52.204-13, System for Award Management Maintenance (Oct 2018)
• The clause at FAR 52.204-18, Commercial and Government Entity Code Maintenance (Jul 2016)
• The clause at FAR 52.212-4, Contract Terms and Conditions - Commercial Items (Oct 2018)
• The clause at HHSAR 352.222-70, Contractor Cooperation in Equal Employement Opportunity Investigations (December 18, 2015)
(xi) The following provisions and clauses apply to this acquisition and are attached in full text:
• The clause at FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items (Oct 2018)
• NIH Invoice and Payment Provisions (2/2014)
(xii) There are no additional contract requirement(s) or terms and conditions applicable to this acquisition.
(xiii) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement.
(xiv) Responses to this solicitation must include sufficient information to establish the interested parties' bona-fide capabilities of providing the product or service. The price quote shall include: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, product or catalog number(s); product description; what the warranty covers; and any other information or factors that may be considered in the award decision. Such factors may include: past performance; special features required for effective program performance; trade-in considerations; probable life of the item selected as compared with that of a comparable item; warranty considerations; maintenance availability; and environmental and energy efficiency considerations.
The Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov."
All responses must be received by 12:00pm EDT on Tuesday, January 8, 2019, and reference solicitation number 75N95019Q00029. Responses may be submitted electronically to Kimberly Espinosa, Contract Specialist, at kimberly.espinosa@nih.gov. Fax responses will not be accepted.
(xv) The name and telephone number of the individual to contact for information regarding the solicitation is Kimberly Espinosa, Contract Specialist, 301-827-3546, kimberly.espinosa@nih.gov.
(xvi) All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency..